Pediatrix Medical Group (NYSE:MD) Director Shirley Weis Sells 36,028 Shares of Stock

Pediatrix Medical Group, Inc. (NYSE:MD) Director Shirley Weis sold 36,028 shares of the firm’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Pediatrix Medical Group Stock Down 2.2%

Pediatrix Medical Group stock opened at $23.45 on Friday. The company has a market capitalization of $1.93 billion, a P/E ratio of 11.38 and a beta of 0.70. The firm’s fifty day simple moving average is $21.49 and its 200-day simple moving average is $21.56. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. Pediatrix Medical Group, Inc. has a 1-year low of $11.84 and a 1-year high of $24.99.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $476.20 million for the quarter, compared to the consensus estimate of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. Pediatrix Medical Group’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.33 EPS. Sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 2.07 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently commented on MD. Mizuho set a $24.00 target price on shares of Pediatrix Medical Group in a report on Friday, May 8th. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 target price on shares of Pediatrix Medical Group in a report on Monday, April 20th. UBS Group lifted their target price on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday. Zacks Research downgraded shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Friday, January 23rd. Finally, Deutsche Bank Aktiengesellschaft set a $19.00 target price on shares of Pediatrix Medical Group in a report on Friday, February 20th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $22.50.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Renaissance Technologies LLC raised its holdings in Pediatrix Medical Group by 12.9% in the 1st quarter. Renaissance Technologies LLC now owns 1,532,300 shares of the company’s stock worth $32,776,000 after acquiring an additional 174,600 shares during the period. Cetera Investment Advisers grew its position in Pediatrix Medical Group by 20.3% in the 1st quarter. Cetera Investment Advisers now owns 20,213 shares of the company’s stock worth $432,000 after purchasing an additional 3,405 shares during the last quarter. First Trust Advisors LP grew its position in Pediatrix Medical Group by 4.6% in the 1st quarter. First Trust Advisors LP now owns 152,876 shares of the company’s stock worth $3,270,000 after purchasing an additional 6,769 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Pediatrix Medical Group by 8.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,856,915 shares of the company’s stock worth $82,496,000 after purchasing an additional 287,696 shares during the last quarter. Finally, Jennison Associates LLC grew its position in Pediatrix Medical Group by 69.5% in the 1st quarter. Jennison Associates LLC now owns 60,846 shares of the company’s stock worth $1,301,000 after purchasing an additional 24,950 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.